Open AccessThe prospects for the SARS ‐CoV‐2 pandemic in Africa
Author(s) -
Quaresima Virginia,
Naldini Matteo M,
Cirillo Daniela M
Publication year - 2020
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.202012488
Subject(s) - pandemic , outbreak , covid-19 , china , government (linguistics) , economic growth , coronavirus , geography , development economics , virology , political science , socioeconomics , medicine , disease , economics , infectious disease (medical specialty) , linguistics , philosophy , archaeology , pathology
On December 31, 2019, the Chinese government officially announced the identification of a new type of coronavirus ( SARS ‐CoV‐2) as the etiological cause of a severe acute respiratory syndrome in Wuhan city, Hubei Province. Over the next weeks, SARS ‐CoV‐2 caused a global pandemic as officially declared by the WHO on March 11, 2020, with confirmed cases and deaths in more than 166 countries. We are experiencing a worldwide phenomenon of unprecedented social and economic consequences. Since the beginning of the COVID ‐19 outbreak, there have been fears that the epidemic could strongly impact weaker healthcare systems in poor‐resource settings, especially in Sub‐Saharan Africa ( SSA ). The 2 million Chinese nationals that live and work in Africa could potentially contribute to the spread of COVID ‐19 on the continent.